Unique Microfluidics engineering maintains consistent process pressure, making sure all material is subjected to the same treatment. The product’s compact design, ease of mobility and small batch capacity ensures cost-effective production with batch-to-batch process repeatability.
The device is recommended for non-sterile processing of:
- Cell disruption
- Nanoemulsions
- Nanodispersions
- Microencapsulation
- Deagglomeration
Analytik product expert James Anderson said: “Building on customer feedback and demand, the new M815 Microfluidizer has been designed from the ground up to fill a gap between the M110EH and the M700 series machines. The M815 represents the next generation of Microfluidizer pilot/production machines with modernized digital control and design and features based around meeting specific customer requirements in GMP laboratories. “
For more information about the M815 Biopharma Microfluidizer, please contact Product Specialist James Anderson
_________________________________________________